ACAP Comments on CY 2026 MA-PD Proposed Rule

On January 27, ACAP submitted its comments to CMS on the CY 2026 Medicare Advantage and Prescription Drug Plan Proposed Rule .

The letter thanks CMS for their leadership in improving the Medicare program for dually eligible beneficiaries and for advancing Medicare and Medicaid integration for these individuals. ACAP respectfully submitted comments in response to the proposed rule, offering support and recommendations on areas, including:

  • Integrated Member ID Cards for D-SNP Applicable Integrated Plans (AIPs);
  • Integrated Health Risk Assessments (HRAs) for D-SNP Applicable Integrated Plans (AIPs);
  • Person-centeredness in SNP Individualized Care Plans (ICPs) and Timeliness of HRAs and ICPs; 
  • Assuring Enrollee Advisory Committee Input on Model of Care (MOC) Updates, Posting State Medicaid Agency Contracts (SMACs) on CMS’ Website, and Clarifying the HIDE SNP Definition for Oregon’s Coordinated Care Organization (CCO) Structure

Read ACAP’s comments in full via the sidebar to the right.